Regenosine
Regenosine is developing a disease-modifying regenerative therapy that utilizes stem cell technology to repair cartilage damage in osteoarthritis patients. This approach aims to reduce pain and improve joint function, addressing the limitations of current symptomatic treatments.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$25KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Regenosine is developing a disease-modifying regenerative therapy that utilizes stem cell technology to repair cartilage damage in osteoarthritis patients. This approach aims to reduce pain and improve joint function, addressing the limitations of current symptomatic treatments.